Biotechnology BioMarin Receives Positive CHMP Opinion in Europe for Valoctocogene Roxaparvovec Gene Therapy to Treat Adults with Severe Hemophilia A June 24, 2022
Biotechnology argenx Receives Positive CHMP Opinion for Efgartigimod for the Treatment of Adult Patients with Generalized Myasthenia Gravis in Europe June 24, 2022
Biotechnology AXSM LOSS ALERT: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AXSM June 23, 2022
Biotechnology CLASS ACTION UPDATE for RSKD, AXSM and SPRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders June 23, 2022
Search
Biotechnology
